CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Journal

publication venue for

Multiple Myeloma in Young Patients: A Scoping Review. 24:15-22. 2024
"Place Matters": Site of Presentation Determines Survival in Immunophenotypically Identical Chronic Lymphoid Neoplasms-a 23-Year SEER Analysis of 118,667 Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2025
Population-Based Competing-Risk Analysis of Survival in Blastic Plasmacytoid Dendritic Cell Neoplasm Before and After CD123-Directed Tagraxofusp Therapy Approval 2025
Sex-Specific Vascular Sequelae of Mediastinal Radiotherapy in Adolescent-and-Young-Adult Hodgkin Lymphoma: A 44-Year SEER Analysis Using Competing-Risk and Life-Years-Lost Modeling 2025
Stage Migration and Survival Trends in Hodgkin Lymphoma, Non-Hodgkin Lymphoma, and Multiple Myeloma, 2000-2017: A SEER Analysis of 393,058 Cases 2025
Survival Disparities in De Novo Versus Secondary Acute Myeloid Leukemia: A 20-Year Population-Based Analysis of 64,624 United States Adults 2025
Therapeutic Era-Driven Survival Trends in Acute Myeloid Leukemia: A SEER-Based Analysis of Age-Stratified Gains and Persistent Disparities (2000-2022) 2025
The Impact of COVID-19 on Acute Myeloid Leukemia (AML): A Propensity Matched Analysis 2024
Multiple Myeloma in Young Patients: A Scoping Review 2024
A Systematic Review and Network Meta-analysis of Randomized Data on Efficacy of Novel Therapy Combinations in Patients with Lenalidomide-refractory Multiple Myeloma 2021

International Standard Serial Number (ISSN)

2152-2650

Electronic International Standard Serial Number (EISSN)

2152-2669

journal abbreviation

CL LYMPH MYELOM LEUK